TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr. Jeff Newell to its Advisory Board

Author's Avatar
Aug 16, 2022

TAMPA, FL / ACCESSWIRE / August 16,2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., announced today the appointment of Jeff Newell to the Company's advisory board. Mr. Newell is expected to serve as a strategic resource to TRxADE as it continues to develop trade relationships in the industry.